U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668336) titled 'A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes' on June 22.
Brief Summary: This study looks at how well a medicine called orforglipron works compared to another medicine called dulaglutide in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how the body processes them.
Participation in the study will last about 61 weeks.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Diabetes Mellitus, Type 2
Intervention:
DRUG: Orforglipron
Administered orally
DRUG: Dulaglut...